Specialty Pharmacy Connect Satellite Symposia
The following listing is provided to you by the Academy of Managed Care Pharmacy as a courtesy; this non-commercial industry-supported Satellite Symposium activity is not part of Specialty Pharmacy Connect/AMCP Managed Care & Specialty Pharmacy Annual Meeting programming, but an important part of our meeting and is planned to meet the same standards of continuing quality education. Satellite Symposia offer continuing pharmacy education (CPE) credit—some also offer continuing medical education (CME) credit, continuing nursing education (CNE) credit, or all three. Satellite Symposium in conjunction with Specialty Pharmacy Connect/AMCP Annual Meeting 2017 are held at the Colorado Convention Center in Denver, Colorado. Any pre-registration taken for this activity is for planning purposes only and does not guarantee a seat. Seating is limited and provided on a first-come, first-served basis. An early arrival is recommended. For additional information about a specific symposium please contact the program manager listed.
|MONDAY, MARCH 27|
|Monday, March 27
6:00 PM – 8:00 PM
The Specialty Pharmacy Review Board™ – Assessing the Value of Novel Therapies and Care Management Strategies for Multiple Sclerosis
Provided by Impact Education, LLC and Medical Education Resources, Inc.
Supported by an independent educational grant from Novartis Pharmaceuticals Corporation
Continuing education credit available for pharmacists and physicians.
Multiple sclerosis (MS) is a complex disease that requires a collaborative approach to care to achieve optimal patient care and outcomes. Disease-modifying therapies (DMTs) are a core component of MS management. Given current constraints on health care expenditures, the relative cost-effectiveness of these therapies needs to be considered when making treatment decisions. Due to a lack of head to head trials it is difficult to determine which therapy would be most effective for MS; however, it is possible to evaluate current therapies based on their effects on sustained disability, relapse rate, lesion load, brain atrophy, and cognitive dysfunction. Members of the clinical team, as well as patients, need to coordinate these efforts when choosing the appropriate therapy and continually monitor the disease, manage symptoms and the psychological aspects of the disease, and engage the patient through coordinated patient education in order to achieve optimal clinical, economic, and humanistic outcomes. Therefore, it is important for specialty pharmacists and managed care professionals to be aware of and engaged in the care and treatment of MS patients. This symposium will provide an update on available treatments, best practices in care coordination among multiple stakeholders, and benefit design considerations to optimize patient outcomes.
The educational format of The Specialty Pharmacy Review Board will feature a multi-specialty, multi-professional faculty that collaborate, under the leadership of an Activity Chair, on the review of the clinical data, current guidelines, and economic data of a class of therapeutics. Similar to a mock pharmacy and therapeutics committee format, the program will include time for peer-to-peer discussion and debate among the diverse group of faculty members and the audience.
Steven Casebeer, MBA
Impact Education, LLC
215-619-8812, extension 102
No Fee Registration: Coming Soon
The Academy of Managed Care Pharmacy (AMCP) does not oversee the content of these symposia and does not provide continuing pharmacy education credit for these educational activities. Opinions expressed during the Satellite Symposia are those of the faculty and are not necessarily a reflection of AMCP’s opinions, nor are they supported, sponsored, or endorsed by AMCP.
© 2017 Academy of Managed Care Pharmacy | 675 North Washington Street, Suite 220, Alexandria, VA 22314 | 703-684-2600 | firstname.lastname@example.org